{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T11:54:53Z","timestamp":1726487693029},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1996,9,1]],"date-time":"1996-09-01T00:00:00Z","timestamp":841536000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drug Ther"],"published-print":{"date-parts":[[1996,9]]},"DOI":"10.1007\/bf00051111","type":"journal-article","created":{"date-parts":[[2004,10,31]],"date-time":"2004-10-31T07:53:25Z","timestamp":1099209205000},"page":"463-466","source":"Crossref","is-referenced-by-count":9,"title":["Should calcium antagonists be first-line agents in the treatment of cardiovascular disease? The public health perspective"],"prefix":"10.1007","volume":"10","author":[{"given":"Curt D.","family":"Furberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce M.","family":"Psaty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2165\/00128413-199409320-00007","volume":"932","author":"K McClellan","year":"1994","unstructured":"McClellan K. Unexpected results from MIDAS in atherosclerosis. Inpharma 1994;932:4.","journal-title":"Inpharma"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/01.CIR.90.1.4","volume":"90","author":"JJ Ferguson","year":"1994","unstructured":"Ferguson JJ, Momomura S. Highlights from the 58th Annual Scientific Meeting of the Japanese Circulation Society. Circulation 1994;90:2194?2196.","journal-title":"Circulation"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1291\/hypres.18.235","volume":"18","author":"The GLANT Study Group","year":"1995","unstructured":"The GLANT Study Group. A 12-month comparison of ACE Inhibitor and Ca antagonist therapy in mild to moderate essential hypertension. The GLANT Study. Hypertens Res 1995;18:235?244.","journal-title":"Hypertens Res"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/jama.1995.03530080036038","volume":"274","author":"BM Psaty","year":"1995","unstructured":"Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with anti-hypertensive drug therapies. JAMA 1995;274:620?625.","journal-title":"JAMA"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1532-5415.1995.tb07393.x","volume":"43","author":"M Pahor","year":"1995","unstructured":"Pahor M, Guralnik JM, Corti M-C, Foley DJ, Carbonin P, Havlik RJ. Long-term survival and use of antihypertensive medications in older persons. J Am Geriatr Soc 1995;43: 1191?1197.","journal-title":"J Am Geriatr Soc"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0140-6736(90)91121-P","volume":"335","author":"PR Lichtlen","year":"1990","unstructured":"Lichtlen PR, Hugenholtz PG, Rafflenbeul W, Hecker H, Jost S, Deckers JW, on behalf of the INTACT group. Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). Lancet 1990;335:1109?1113.","journal-title":"Lancet"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1161\/01.CIR.82.6.1940","volume":"82","author":"D Waters","year":"1990","unstructured":"Waters D, Lesperance J, Francetich M, et al. A controlled clinical trial to assess the effect of a calcium channel blocker upon the progression of coronary atherosclerosis. Circulation 1990;82:1940?1953.","journal-title":"Circulation"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1161\/01.CIR.84.6.2398","volume":"84","author":"U Thadani","year":"1991","unstructured":"Thadani U, Zellner SR, Glasser S, et al. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris. Circulation 1991;84:2398?2408.","journal-title":"Circulation"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0002-9149(93)90735-U","volume":"71","author":"K Egstrup","year":"1993","unstructured":"Egstrup K, Andersen PE. Transient myocardial ischemia during nifedipine therapy in stable angina pectoris, and its relation to coronary collateral flow and comparison with metoprolol. Am J Cardiol 1993;71:177?183.","journal-title":"Am J Cardiol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/01.CIR.92.5.1326","volume":"92","author":"CD Furberg","year":"1995","unstructured":"Furberg CD, Psaty BM, Meyer JV. Nifedipine: Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326?1331.","journal-title":"Circulation"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/0002-9149(91)90944-G","volume":"67","author":"S Yusuf","year":"1991","unstructured":"Yusuf S, Held P, Furberg C. Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies. Am J Cardiol 1991;67:1295?1297.","journal-title":"Am J Cardiol"},{"key":"CR12","first-page":"2815","volume-title":"Hypertension. Pathophysiology, Diagnosis and Management","author":"M Ruzicka","year":"1995","unstructured":"Ruzicka M, Leenen FHH. Relevance of intermittent increases in sympathetic activity for adverse outcome on short-acting calcium antagonists. In: Laragh JH, Brenner BM, eds. Hypertension. Pathophysiology, Diagnosis and Management. New York: Raven Press, 1995: 2815?2825."},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0140-6736(96)90276-7","volume":"347","author":"M Pahor","year":"1996","unstructured":"Pahor M, Guralnik JM, Furberg CD, Carbonin P, Havlik RJ. Risk of gastrointestinal hemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet 1996;347:1061?1065.","journal-title":"Lancet"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1056\/NEJM199511233332117","volume":"333","author":"AN Crowson","year":"1995","unstructured":"Crowson AN, Magro CM. Diltiazem and subacute cutaneous lupus erythematosus-like lesions. N Eng J Med 1995; 333:1428.","journal-title":"N Eng J Med"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1001\/archinte.1995.00430200036007","volume":"155","author":"CD Furberg","year":"1995","unstructured":"Furberg CD, Psaty BM. Should dihydropyridines be used as first-line drugs in the treatment of hypertension? The con side. Arch Intern Med 1995;155:2157?2161.","journal-title":"Arch Intern Med"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0895-7061(96)00014-3","volume":"9","author":"CD Furberg","year":"1996","unstructured":"Furberg CD, Psaty BM. Calcium antagonists: Not appropriate as first-line antihypertensive agents. Am J Hypertens 1996;9:122?125.","journal-title":"Am J Hypertens"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00051111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00051111\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00051111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T03:50:17Z","timestamp":1554263417000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00051111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,9]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1996,9]]}},"alternative-id":["BF00051111"],"URL":"https:\/\/doi.org\/10.1007\/bf00051111","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,9]]}}}